Aksu, Ali Cenk; Cabrales, Pedro; Cirrik, Selma; Oronsky, Bryan; Ugurel, Elif; Yalcin, Ozlem
(IOS PRESS, NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS, 2019)
BACKGROUND: RRx-001 is an anti-cancer immunotherapeutic that increases the sensitivity of drug resistant tumors via multiple mechanisms which involve binding to hemoglobin and enhancing nitrite reductase activity of ...